Abstract
Anemia is a common blood disorder characterized by a decrease in the number of red blood cells or hemoglobin levels, leading to symptoms such asfatigue, weakness, and shortness of breath. Pharmacotherapy plays a crucial role in managing anemia by addressing underlying causes and restoring normal hemoglobin levels. This article explores the current state of pharmacological treatments for anemia, including erythropoiesis-stimulating agents, iron supplements, and newer innovative therapies such as erythroid maturation agents. It also discusses the challenges and future directions in the field of anemia pharmacotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Sciences And Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
